Plus Therapeutics (FRA:XMP0) Interest Expense : €-0.37 Mil (TTM As of Dec. 2023)

View and export this data going back to . Start your Free Trial

What is Plus Therapeutics Interest Expense?

Interest Expense is the amount reported by a company or individual as an expense for borrowed money. Plus Therapeutics's interest expense for the three months ended in Dec. 2023 was € -0.06 Mil. Its interest expense for the trailing twelve months (TTM) ended in Dec. 2023 was €-0.37 Mil.

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income(EBIT) by its Interest Expense. Plus Therapeutics's Operating Income for the three months ended in Dec. 2023 was € -3.54 Mil. Plus Therapeutics's Interest Expense for the three months ended in Dec. 2023 was € -0.06 Mil. Plus Therapeutics did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is. Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Plus Therapeutics Interest Expense Historical Data

The historical data trend for Plus Therapeutics's Interest Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Plus Therapeutics Interest Expense Chart

Plus Therapeutics Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Interest Expense

Get a 7-Day Free Trial

-1.67

-0.91

-0.83

-0.67

-0.36

Plus Therapeutics Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Interest Expense	Get a 7-Day Free Trial															-0.15	-0.13	-0.10	-0.08	-0.06

Plus Therapeutics Interest Expense Calculation

Interest Expense is the amount reported by a company or individual as an expense for borrowed money.

Interest Expense for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was €-0.37 Mil.

Plus Therapeutics (FRA:XMP0) Interest Expense Explanation

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Plus Therapeutics's Interest Expense for the three months ended in Dec. 2023 was €-0.06 Mil. Its Operating Income for the three months ended in Dec. 2023 was €-3.54 Mil. And its Long-Term Debt & Capital Lease Obligation for the three months ended in Dec. 2023 was €0.08 Mil.

Plus Therapeutics's Interest Coverage for the quarter that ended in Dec. 2023 is calculated as

Plus Therapeutics did not have earnings to cover the interest expense.

The higher the ratio, the stronger the company's financial strength is.

Plus Therapeutics (FRA:XMP0) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Plus Therapeutics Inc (FRA:XMP0) » Definitions » Interest Expense

Comparable Companies

Traded in Other Exchanges

PSTV:USA

Address

4200 Marathon Boulevard, Suite 200, Austin, TX, USA, 78756

Website

https://www.plustherapeutics.com

Plus Therapeutics Inc is a clinical-stage pharmaceutical company. The company focused on the discovery, development, and delivery of complex and innovative treatments for patients battling cancer and rare diseases. Its product pipeline includes Patented RNL and Patented DocePLUS.

Plus Therapeutics (FRA:XMP0) Headlines

No Headlines